Latest raise
$18M
Date raised
October 12, 2026
Round
Seed
Investors4BIO Capital, IQ Capital
Websiteundecimalbio.com
About Yaniv Erlich
a spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics
- Who is Yaniv Erlich?
- Yaniv Erlich is listed as Co-founder and CEO of Undecimal Bio, a biotechnology company based in Cambridge, United Kingdom.
- How much did Undecimal Bio raise?
- Undecimal Bio raised $18M in a Seed round on October 12, 2026 (21 days ago). Backed by 4BIO Capital, IQ Capital.
Get newly funded founders every week
A free weekly list of startups that just raised.